Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, (-)-BPAP

Life sciences

Volumn 71, Issue 18, 2002, Pages 2137-2144

  Knoll, Joseph ^a   Miklya, Ildikó ^b   Knoll, Berta ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1 (BENZOFURAN 2 YL) 2 PROPYLAMINOPENTANE; 1-(BENZOFURAN-2-YL)-2-PROPYLAMINOPENTANE; BENZOFURAN DERIVATIVE; CATECHOLAMINE; DOPAMINE; SEROTONIN;

ANIMAL; ARTICLE; BRAIN LEVEL; DOSE RESPONSE; DRUG EFFECT; METABOLISM; NERVE CELL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BENZOFURANS; BRAIN CHEMISTRY; CATECHOLAMINES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SUBCUTANEOUS; NEURONS; RATS; SEROTONIN;

EID: 0037144330     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01969-0     Document Type: Article

References (12)

1. B. Borowsky N. Adham K.A. Jones R. Raddatz R. Artimishyn K.L. Ogozalek M.M. Durkin P.P. Lakhlani J.A. Bonini S. Pathirana N. Boyle X. Pu E. Kouranova H. Lichtblau F.Y. Ochoa T.A. Branchek C. Gerald Trace amines: Identification of a family of mammalian G protein-coupled receptors Proceedings National Academy of Sciences USA 98 16 2001 8966 8971
2. W. Hamabe R. Fujita T. Yasusa F. Yoneda A. Yoshida H. Ueda (−)1-(Benzofuran-2-yl)-2-propylaminopentane shows survival effect on cortical neurons under serum-free condition through sigma receptors Cellular and Molecular Neurobiology 20 6 2000 695 702
3. J. Knoll Memories of 45 years in research Pharmacology and Toxicology 75 1994 65 72
4. J. Knoll (−)Deprenyl (Selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain Pharmacology and Toxicology 82 1998 57 66
5. J. Knoll Antiaging compounds: (−)Deprenyl (Selegiline) and (−)1-(benzofuran-2-yl)-2-propylaminopentane, [(−)BPAP], a selective, highly potent enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain CNS Drug Reviews 7 3 2001 317 345
6. J. Knoll I. Miklya Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity. Rationale for prophylactic (−)deprenyl (selegiline) medication Life Sciences 56 1995 611 620
7. J. Knoll I. Miklya B. Knoll R. Markó K. Kelemen (−)Deprenyl and (−)1- phenyl-2-propylaminopentane, [(−)PPAP], act primarily as potent stimulants of action potential -transmitter release coupling in the catecholaminergic neurons Life Sciences 58 1996 817 827
8. J. Knoll I. Miklya B. Knoll R. Markó D. Rácz Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain Life Sciences 58 1996 2101 2114
9. J. Knoll F. Yoneda B. Knoll H. Ohde I. Miklya (−)l-(Benzofuran-2-yl)-2-propylaminopentane, [(−)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain British Journal of Pharmacology 128 1999 1723 1732
10. T. Oka T. Yasusa T. Ando M. Watanabe F. Yoneda T. Ishida J. Knoll Enantioselective synthesis and absolute configuration of (−)1-(benzofuran-2-yl)-2-propylaminopentane, (−)-BPAP, a highly potent and selective catecholaminergic activity enhancer Bioorganic and Medicinal Chemistry 9 2001 1213 1219
11. M.H. Rashid T. Matsumoto K. Mizuno M. Watanabe N. Sato F. Yoneda H. Ueda Nociceptive responses by deprenyl derivative, (−)BPAP through metabotropic sigma receptor Pharmacology Reviews and Communications 11 4 2001 335 342
12. F. Yoneda T. Moto M. Sakae H. Ohde B. Knoll I. Miklya J. Knoll Structure-activity studies leading to (−)1-(benzofuran-2-yl)-2-propylaminopentane, (−)BPAP, a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain Bioorganic and Medicinal Chemistry 9 2001 1197 1212